IL1RAP expression has been reported in adult-type AML on both bulk leukemic cells and LSCs [21], and IL1RAP-targeted CAR-T-cells are currently being evaluated in a clinical trial (NCT04169022) in adult AML. This evidence concerns the gene IL1RAP and acute myeloid leukemia.